옵션 체인은 다양한 행사가격과 만기일에 대한 VYNE Therapeutics의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 VYNE Therapeutics에 대한 시장 심리를 평가합니다..

VYNE Therapeutics (NASDAQ:VYNE) 주식, 옵션 체인

VYNE THERAPEUTICS INC

VYNE Therapeutics

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.

VYNE Therapeutics Inc

eridianbet, the sports betting and iGaming division of Golden Matrix Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GMGI#NASDAQ">GMGI</a>), a leading developer and licensor of B2B and B2C gaming platforms, today announced the signing of a two-year exclusive sponsorship agreement with the Aquatic Sports Association of Malta (ASA), the official governing body for water polo, swimming, and artistic swimming in Malta.
Under the terms of the agreement, Meridianbet becomes the exclusive betting partner of ASA, gaining integrated brand exposure across ASA events, digital platforms, and physical venues. The sponsorship includes the launch of the branded national cup competition - Meridianbet Super Cup, as well as LED road signage, scoreboard branding, and apparel sponsorships across Malta's aquatic sports federations.

News

GMGI

Golden Matrix Group's Meridianbet Signs 2-Yr Exclusive Sponsorship Agreement With Aquatic Sports Association Of Malta

Goldman Sachs analyst Noah Poponak maintains Parsons (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSN#NYSE">PSN</a>) with a Buy and lowers the price target from $90 to $80.

Price Target

Analyst Ratings

Goldman Sachs Maintains Buy on Parsons, Lowers Price Target to $80

Goldman Sachs analyst Christine Cho maintains Jack In The Box (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JACK#NASDAQ">JACK</a>) with a Sell and lowers the price target from $24 to $19.

JACK

Goldman Sachs Maintains Sell on Jack In The Box, Lowers Price Target to $19

Dollar General Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DG#NYSE">DG</a>) reported better-than-expected first-quarter earnings and <a href="https://www.benzinga.com/quote/DG/earnings">raised its full-year outlook on Tuesday.</a>
The general store operator said quarterly net sales increased 5.3% to $10.44 billion, barely missing the consensus of $10.64 billion. The company reported net income of $391.9 million, up 7.9%, with earnings of $1.78 per share, compared to $1.65 a year ago, beating the consensus of $1.58.
&#8220;We are pleased with our start to the year, including strong same-store sales and EPS results,&#8221; said Todd Vasos, Dollar General&#8217;s chief executive officer. &#8220;Our efforts to improve execution and enhance the associate and customer experience are yielding positive outcomes in both our operational performance and our financial results. I want to thank our team for their hard work and dedication to serving our customers and communities with value and convenience every day. These efforts contributed to market share gains in sales of both consumables and non-consumables, and drove growth with both our core customer and trade-in customers during the quarter.&#8221;
The company is updating its expectations for the year, primarily to reflect its outperformance in the first quarter and the tariff uncertainty. The company now expects fiscal year 2025 sales growth of approximately 3.7% to 4.7%, compared to its previous expectation of approximately 3.4% to 4.4%.
Dollar General revised earnings guidance from $5.10-$5.80 per share to $5.20-$5.80 compared to the consensus of $5.62.
Dollar General shares fell 1% to $111.57 on Wednesday.
These analysts made changes to their price targets on Dollar General following earnings announcement.
<ul class="wp-block-list">
<li>Telsey Advisory Group analyst Joseph Feldman maintained Dollar General with a Market Perform and raised the price target from $100 to $120.</li>
<li>Barclays analyst Karen Short maintained the stock with an Overweight rating and raised the price target from $100 to $119.</li>
<li>B of A Securities analyst Robert Ohmes maintained Dollar General with a Buy and raised the price target from $115 to $135.</li>
<li>Wells Fargo analyst Edward Kelly maintained the stock with an Equal-Weight rating and raised the price target from $80 to $105.</li>
<li>UBS analyst Michael Lasser maintained Dollar General with a Buy and raised the price target from $120 to $128.</li>
<li>JP Morgan analyst Matthew Boss maintained the stock with a Neutral and raised the price target from $88 to $95.</li>
<li>Morgan Stanley analyst Simeon Gutman maintained Dollar General with an Equal-Weight rating and raised the price target from $85 to $115.</li>
<li>Truist Securities analyst Scot Ciccarelli maintained the stock with a Hold and raised the price target from $93 to $112.</li>
<li>Raymond James analyst Bobby Griffin maintained Dollar General with an Outperform rating and raised the price target from $100 to $125.</li>
<li>Citigroup analyst Paul Lejuez maintained the stock with a Neutral and raised the price target from $101 to $112.</li>
</ul>
Considering buying DG stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/DG/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="585" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/04134406/image-54-1024x585.png" alt="" class="wp-image-938629" style="width:630px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/04134406/image-54-1024x585.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/04134406/image-54-300x172.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/04134406/image-54-768x439.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/04134406/image-54.png 1102w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/25/06/45762621/cramer-shouldve-told-investors-to-pull-the-trigger-on-trade-desk-cant-believe-how-low-gentex-has-fal">Cramer: Should&#8217;ve Told Investors To &#8216;Pull The Trigger&#8217; On Trade Desk, Can&#8217;t Believe &#8216;How Low&#8217; Gentex Has Fallen</a></li>
</ul>
Photo via Shutterstock

Earnings

Markets

Trading Ideas

These Analysts Increase Their Forecasts On Dollar General After Better-Than-Expected Q1 Earnings

Citigroup analyst Andrew Kaplowitz maintains Honeywell Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HON#NASDAQ">HON</a>) with a Buy and raises the price target from $242 to $265.

Citigroup Maintains Buy on Honeywell Intl, Raises Price Target to $265

Goldman Sachs analyst David Roman maintains HealthEquity (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HQY#NASDAQ">HQY</a>) with a Neutral and raises the price target from $94 to $104.

Goldman Sachs Maintains Neutral on HealthEquity, Raises Price Target to $104

Goldman Sachs analyst Adam Hotchkiss maintains Guidewire Software (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWRE#NYSE">GWRE</a>) with a Buy and raises the price target from $235 to $270.

GWRE

Goldman Sachs Maintains Buy on Guidewire Software, Raises Price Target to $270

Goldman Sachs analyst Kate McShane maintains Dollar General (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DG#NYSE">DG</a>) with a Buy and raises the price target from $96 to $115.

Goldman Sachs Maintains Buy on Dollar General, Raises Price Target to $115

Citigroup analyst Andrew Kaplowitz maintains Emerson Electric (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMR#NYSE">EMR</a>) with a Buy and raises the price target from $133 to $146.

Citigroup Maintains Buy on Emerson Electric, Raises Price Target to $146

B. Riley Securities analyst Naved Khan upgrades Yext (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YEXT#NYSE">YEXT</a>) from Neutral to Buy and raises the price target from $7 to $10.

Upgrades

YEXT

B. Riley Securities Upgrades Yext to Buy, Raises Price Target to $10

B. Riley Securities analyst Anna Glaessgen reiterates Sportsman's Warehouse (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPWH#NASDAQ">SPWH</a>) with a Buy and raises the price target from $3 to $4.

Reiteration

SPWH

B. Riley Securities Reiterates Buy on Sportsman's Warehouse, Raises Price Target to $4

<a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45762633/anthony-scaramucci-agrees-bitcoin-skeptic-jamie-dimon-would-be-a-welcome-alternative-as-president">JPMorgan Chase</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NASDAQ">JPM</a>) is preparing to allow clients in its trading and wealth management divisions to use certain cryptocurrency-related assets, specifically Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) ETFs, as collateral for loans.
What Happened: Quoting unnamed sources, Bloomberg <a href="https://www.bloomberg.com/news/articles/2025-06-04/jpmorgan-plans-to-offer-clients-financing-against-crypto-etfs?utm_medium=email&amp;utm_source=author_alert&amp;utm_term=250604&amp;utm_campaign=author_22647091&amp;embedded-checkout=true">reported </a>that the bank will initially begin offering financing backed by BlackRock's iShares Bitcoin Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBIT#NASDAQ">IBIT</a>).
The change marks a significant policy adjustment as traditional financial institutions respond to regulatory shifts and growing client demand following the election of President Donald Trump, whose administration has taken a notably pro-crypto stance.
In addition to accepting Bitcoin ETFs for lending purposes, JPMorgan also intends to factor clients' crypto holdings into wealth assessments. 
The inclusion would place cryptocurrencies alongside more traditional assets such as equities, real estate, or collectibles in determining a client's borrowable value.
Though JPMorgan has declined to comment publicly on the developments, the move would build on its existing ties to the crypto space. 
The bank has long served clients like Coinbase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) and was among the earliest financial giants to deploy blockchain-based payment services.
Also Read: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45775027/pump-funs-1b-token-plan-risks-undermining-solana-defi-fueling-meme-coin-scams-experts-warn">Pump.fun&#8217;s $1B Token Plan Risks Undermining Solana DeFi, Fueling Meme Coin Scams, Experts Warn</a>
Why It Matters: Despite CEO Jamie Dimon&#8216;s <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45501880/jamie-dimon-opens-jpmorgan-to-bitcoin-access-despite-longstanding-criticism">personal skepticism</a>—he has said he's "not a fan" of Bitcoin—he has expressed support for client autonomy in digital asset investing.
"I don't think we should smoke, but I defend your right to smoke," he said in May. "I defend your right to buy Bitcoin, go at it."
The new lending framework is expected to be rolled out across JPMorgan's global wealth management segments, encompassing all client tiers, from everyday investors to high-net-worth individuals. 
Previously, crypto ETFs were considered as loan collateral only in isolated cases.
<a href="https://www.benzinga.com/money/best-spot-bitcoin-etfs">Spot Bitcoin ETFs</a>, introduced in the U.S. in January 2024, have since grown rapidly to manage over $128 billion in assets, ranking among the most successful ETF launches on record.
Meanwhile, Bitcoin's price has surged, hitting a peak of $111,980 in May, bolstered by Trump's election victory in November and his administration's crypto-friendly policies.
Industry donations have played a role in reshaping Washington's stance on digital assets, with Trump advocating several pro-crypto measures since taking office. 
His own family businesses have expanded into crypto ventures, including Bitcoin mining operations and memecoin initiatives, further signaling the asset class's growing political and financial influence.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45772954/can-bitcoin-boost-portfolio-returns-without-increasing-risk-bitwises-matt-hougan-says-it-can">Can Bitcoin Boost Portfolio Returns Without Increasing Risk? Bitwise&#8217;s Matt Hougan Says It Can</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

COIN

IBIT

JPMorgan To Accept Crypto-Linked ETFs As Loan Collateral

B. Riley Securities analyst Dave Kang maintains Lumentum Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LITE#NASDAQ">LITE</a>) with a Neutral and raises the price target from $65 to $73.

LITE

B. Riley Securities Maintains Neutral on Lumentum Holdings, Raises Price Target to $73

B. Riley Securities analyst Nick Giles maintains Applied Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLD#NASDAQ">APLD</a>) with a Buy and raises the price target from $8 to $15.

APLD

B. Riley Securities Maintains Buy on Applied Digital, Raises Price Target to $15

<a href="https://www.wsj.com/tech/ai/reddit-lawsuit-anthropic-ai-3b9624dd?msockid=21c662101c496b42343370ae1de86aaa">https://www.wsj.com/tech/ai/reddit-lawsuit-anthropic-ai-3b9624dd?msockid=21c662101c496b42343370ae1de86aaa</a>

General

AMZN

GOOG

GOOGL

RDDT

'Reddit Sues Anthropic, Alleges Unauthorized Use of Site's Data'- WSJ

Stifel analyst Steven Wieczynski maintains Royal Caribbean Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCL#NYSE">RCL</a>) with a Buy and raises the price target from $275 to $310.

Stifel Maintains Buy on Royal Caribbean Gr, Raises Price Target to $310

WIIM

MULN

Mullen Automotive shares are trading higher after the company announced it entered into securities purchase agreements following its 1-for-100 reverse stock split.

Stifel analyst Parker Lane maintains Guidewire Software (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWRE#NYSE">GWRE</a>) with a Buy and raises the price target from $230 to $270.

Stifel Maintains Buy on Guidewire Software, Raises Price Target to $270

Stifel analyst Adam Borg maintains CrowdStrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) with a Buy and raises the price target from $480 to $495.

CRWD

Stifel Maintains Buy on CrowdStrike Holdings, Raises Price Target to $495

Guidewire Software, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWRE#NYSE">GWRE</a>) reported better-than-expected third-quarter financial <a href="https://www.benzinga.com/quote/GWRE/earnings">results on Tuesday</a>.
Guidewire Software reported quarterly earnings of 88 cents per share which beat the analyst consensus estimate of 47 cents per share. The company reported quarterly sales of $293.51 million which beat the analyst consensus estimate of $286.39 million.
&#8220;We delivered exceptional third-quarter results, highlighted by record Q3 sales activity and 17 cloud deals,&#8221; said Mike Rosenbaum, chief executive officer, Guidewire. &#8220;With Guidewire established as the clear worldwide leader in P&amp;C core systems, we&#8217;re increasing our market engagement activity, hosting our largest ever industry events in Paris, Tokyo, and Sydney, and our second annual Developer Summit in Bangalore, where we activated the industry&#8217;s largest developer ecosystem.&#8221;
Guidewire Software shares jumped 19.1% to $259.83 on Wednesday.
These analysts made changes to their price targets on Guidewire Software following earnings announcement.
<ul class="wp-block-list">
<li>JMP Securities analyst Aaron Kimson maintained Guidewire Software with a Market Outperform and raised the price target from $250 to $281.</li>
<li>Wells Fargo analyst Michael Turrin maintained the stock with an Overweight rating and raised the price target from $220 to $265.</li>
<li>B of A Securities analyst Brad Sills maintained Guidewire Software with an Underperform rating and raised the price target from $135 to $160.</li>
<li>RBC Capital analyst Rishi Jaluria maintained the stock with an Outperform rating and raised the price target from $230 to $290.</li>
<li>Oppenheimer analyst Ken Wong maintained Guidewire with an Outperform rating and raised the price target from $230 to $275.</li>
<li>JP Morgan analyst Alexei Gogolev maintained the stock with an Overweight rating and raised the price target from $231 to $271.</li>
<li>Raymond James analyst Alexander Sklar maintained Guidewire Software with an Outperform rating and raised the price target from $225 to $255.</li>
</ul>
Considering buying GWRE stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="542" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/04133259/image-53-1024x542.png" alt="" class="wp-image-938616" style="width:652px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/04133259/image-53-1024x542.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/04133259/image-53-300x159.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/04133259/image-53-768x407.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/04133259/image-53.png 1071w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/25/06/45762621/cramer-shouldve-told-investors-to-pull-the-trigger-on-trade-desk-cant-believe-how-low-gentex-has-fal">Cramer: Should&#8217;ve Told Investors To &#8216;Pull The Trigger&#8217; On Trade Desk, Can&#8217;t Believe &#8216;How Low&#8217; Gentex Has Fallen</a> </li>
</ul>
Photo via Shutterstock

Comments

VYNE Therapeutics

VYNE Therapeutics (VYNE) 옵션

No option chain data available. Please try again later

뉴스

파트너 / 기고자

벤징가 글로벌